✦ LIBER ✦

Association of tardive dyskinesia with increased frequency of eye movement disturbances in chronic schizophrenic patients

✍ Scribed by Godehard Oepen; Uwe Thoden; Christoph Warmke

Publisher: Springer-Verlag
Year: 1990
Tongue: English
Weight: 647 KB
Volume: 239
Category: Article
ISSN: 1433-8491
DOI: 10.1007/bf01738578

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Tardive dyskinesia in a chronically inst

Tardive dyskinesia in a chronically institutionalized population of elderly schizophrenic patients: prevalence and association with cognitive impairment

✍ William Byne; Leonard White; Michael Parella; Rebecca Adams; Philip D. Harvey; K 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 121 KB 👁 2 views

## Background: Chronically hospitalized geriatric inpatients with schizophrenia are at particular risk for both tardive dyskinesia (td) and cognitive impairment but have been insufficiently studied in this regard. similarly, the relationship between td and cognitive impairment has not be adequately

Evidence for association of the GLI2 gen

Evidence for association of the GLI2 gene with tardive dyskinesia in patients with chronic schizophrenia

✍ Lior Greenbaum; Anna Alkelai; Amihai Rigbi; Yoav Kohn; Bernard Lerer 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 97 KB 👁 1 views

## Abstract Tardive dyskinesia (TD) occurs in approximately 20% of patients exposed to long‐term antipsychotic treatment and may be influenced by genetic predisposition, in addition to clinical risk factors. In this study, we implemented a two‐step approach to identify susceptibility genes for TD.

Association of dopamine D3-receptor gene

Association of dopamine D3-receptor gene variants with neuroleptic induced akathisia in schizophrenic patients: A generalization of Steen's study onDRD3 and tardive dyskinesia

✍ Eichhammer, P. ;Albus, M. ;Borrmann-Hassenbach, M. ;Schoeler, A. ;Putzhammer, A. 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 17 KB 👁 3 views

Neuroleptic induced akathisia is a common and distressful extrapyramidal side effect of antipsychotic treatment. A significant proportion of the variability of its development has been left unexplained and has to be attributed to individual susceptibility. Since hereditary factors have been discusse